Solifenacin succinate tablets 2.5 mg “Tsuruhara” (Tsuruhara Pharmaceutical) are indicated for the symptomatic treatment of overactive bladder. This includes addressing urinary urgency, frequent urination, and urge incontinence, with a YJ code of 2590011F1060 and a standard of 2.5 mg per tablet.
Solifenacin succinate tablets 2.5 mg “Tsuruhara”
Need more detailed information?
Contact TASAKI PHARMA for inquiries about this medicine (English support available).
Contact us about this drug →More with the same ingredient
